Studies related to Prostate Cancer Risk and Selenium

Selenium And Prostate Cancer: Systematic Review And Meta-analysis

Effect Decrease
Trial Design Meta analysis
Trial Length n/a
Number of Subjects 12
Sex n/a
Notes for this study:
A relative decrease in prostate cancer risk is seen when 170ng/mL (circulating selenium levels) is compared to 60ng/mL, where the former value has a 0.8 relative risk when compared to the latter; a slight, but statistically significant reduction in risk.